This week in Washington IP news, the Senate Judiciary Committee will consider a series of bills that could limit pharmaceutical patent owners’ ability to enforce their patents against generic drug makers. Over in the House of Representatives, the House Science Committee will mark up a series of bills to support research and development as well as technology transfer and commercialization, while the House Europe Subcommittee will explore international case studies in offshore wind renewable energy innovation. Elsewhere, the American Enterprise Institute focuses on developments in the private commercial space sector, while the USPTO celebrates 75 years of the Lanham Act’s codification of U.S. trademark law this Tuesday.
Recent Posts
- Call Off Chicken Little: The Sky is Not Falling for Skinny Labeling After GSK v. Teva
- CAFC Committee Recommends Another Year of Sanctions Against Newman
- Massie Tells House IP Subcommittee Witnesses He’s ‘Appalled’ By Proposals to Rein in ITC’s Patent Powers
- CAFC Invalidates Remaining Claim on Data Transmission Patent, Remands Substitute Claims for Collateral Estoppel Determination
- NIH Intramural Licensing Guidelines Hit the Wrong Note at the Wrong Time